Genomic Screening in Vivo Reveals the Role Played by Vacuolar H+ ATPase and Cytosolic Acidification in Sensitivity to DNA-Damaging Agents Such as Cisplatin
Authors:
- Bin HuBHBin Hu
- Matthew J. ArnoMAMatthew J. Arno
- Barry PanaretouBPBarry Panaretou
- 1 February 2007
- journal article
- Published by Elsevier in Molecular Pharmacology
- Vol. 71 (2) , 416-425
Abstract
Screening the Saccharomyces cerevisiae homozygous diploid deletion library against a sublethal concentration of cisplatin revealed 76 strains sensitive to the drug. As expected, the largest category of deletions, representing 40% of the sensitive strains, was composed of strains lacking genes involved in DNA replication and damage repair. Deletions lacking function of the highly conserved vacuolar H+ translocating ATPase (V-ATPase) composed the category representing the second largest number of sensitive strains. The effect on cell death exhibited by V-ATPase mutants was found to be a general response to various DNA damaging agents as opposed to being specific to cisplatin, as evidenced by sensitivity of the mutants to hydroxyurea (a DNA-alkylating agent) and UV irradiation. Loss of V-ATPase does not affect DNA repair, because double mutants defective for V-ATPase function and DNA repair pathways were more sensitive to cisplatin than the single mutants. V-ATPase mutants are more prone to DNA damage than wild-type cells, indicated by enhanced activation of the DNA damage checkpoint. Vacuole function per se is not cisplatin-sensitive, because vacuolar morphology and vacuolar acidification were unaffected by cisplatin in wild-type cells. V-ATPase also controls cytoplasmic pH, so the enhanced sensitivity to DNA damage may be associated with the drop in pHi associated with V-ATPase mutants. The increased loss in cell viability induced by cisplatin at lower pH in V-ATPase mutants supports this hypothesis. The loss in viability seen in wild-type cells under the same conditions was far less dramatic.Keywords
This publication has 39 references indexed in Scilit:
- Histone H2B Deacetylation at Lysine 11 Is Required for Yeast Apoptosis Induced by Phosphorylation of H2B at Serine 10Molecular Cell, 2006
- Identification by Functional Cloning from a Retroviral cDNA Library of cDNAs for Ribosomal Protein L36 and the 10-kDa Heat Shock Protein that Confer Cisplatin ResistanceMolecular Pharmacology, 2006
- Genome-Wide Screen Identifies Genes Whose Inactivation Confer Resistance to Cisplatin inSaccharomyces cerevisiaeCancer Research, 2005
- Cellular processing of platinum anticancer drugsNature Reviews Drug Discovery, 2005
- Apoptosis in yeastCurrent Opinion in Microbiology, 2004
- DNA Damage-Processing Pathways Involved in the Eukaryotic Cellular Response to Anticancer DNA Cross-Linking DrugsMolecular Pharmacology, 2004
- Anticancer Drug Resistance Induced by Disruption of the Saccharomyces cerevisiae NPR2 Gene: a Novel Component Involved in Cisplatin- and Doxorubicin-Provoked Cell KillMolecular Pharmacology, 2003
- Enhanced Expression of the Human Vacuolar H+-ATPase c subunit Gene (ATP6L) in Response to Anticancer AgentsJournal of Biological Chemistry, 2002
- A Genome-Wide Screening in Saccharomyces cerevisiae for Genes That Confer Resistance to the Anticancer Agent CisplatinBiochemical and Biophysical Research Communications, 2000
- Cellular and molecular determinants of cisplatin resistanceEuropean Journal of Cancer, 1998